We are live on ! Find out more
PWM

Palumbo Wealth Management Portfolio holdings

AUM $410M
1-Year Est. Return 32.56%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
+32.56%
3 Year Est. Return
+80.66%
5 Year Est. Return
+99.66%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$31.3M
Cap. Flow
+$33.1M
Cap. Flow %
11.06%
Top 10 Hldgs %
39.82%
Holding
199
New
24
Increased
127
Reduced
28
Closed
12

Top Buys

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$2.05M
2
AAPL icon
Apple
AAPL
+$1.7M
3
NVDA icon
NVIDIA
NVDA
+$1.64M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$1.44M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.8M
2
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.21M
3
WGS icon
GeneDx Holdings
WGS
+$638K
4
CRWD icon
CrowdStrike
CRWD
+$439K
5
NOW icon
ServiceNow
NOW
+$359K

Sector Composition

Rank Sector Weight
1 Technology 15.17%
2 Healthcare 8.12%
3 Financials 7.99%
4 Consumer Discretionary 7.11%
5 Industrials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DFTX
176
Definium Therapeutics
DFTX
$6.12B
$132K 0.04%
+22,628
New +$162K
QS icon
177
QuantumScape Corp
QS
$3.4B
$131K 0.04%
+31,456
New +$155K
CGEM icon
178
Cullinan Oncology
CGEM
$1.1B
$123K 0.04%
+16,268
New +$156K
ASRT
179
DELISTED
Assertio
ASRT
$115K 0.04%
11,412
-2,295
-17% -$27.4K
BWAY
180
Brainsway
BWAY
$628M
$111K 0.04%
+23,546
New +$120K
GRCE
181
Grace Therapeutics
GRCE
$34.5M
$105K 0.04%
+46,007
New +$145K
VERV
182
DELISTED
Verve Therapeutics
VERV
$72.4K 0.02%
+15,845
New +$106K
ELEV
183
DELISTED
Elevation Oncology
ELEV
$72K 0.02%
278,002
+208,897
+302% +$119K
ERAS icon
184
Erasca
ERAS
$6.34B
$59.4K 0.02%
43,331
+14,731
+52% +$25.3K
NAUT icon
185
Nautilus Biotechnolgy
NAUT
$113M
$35.4K 0.01%
41,162
+12,687
+45% +$18.9K
VTYX
186
DELISTED
Ventyx Biosciences
VTYX
$30.5K 0.01%
26,498
+2,566
+11% +$4.41K
INZY
187
DELISTED
Inozyme Pharma
INZY
$27.1K 0.01%
29,784
+6,503
+28% +$9.01K
BIB icon
188
ProShares Ultra NASDAQ Biotechnology
BIB
$83.2M
– –
-4,000
Closed -$203K
CRDO icon
189
Credo Technology Group
CRDO
$43B
– –
-3,832
Closed -$258K
CRTO icon
190
Criteo S.A. Ordinary Shares
CRTO
$883M
– –
-5,264
Closed -$208K
DNA icon
191
Ginkgo Bioworks
DNA
$555M
– –
-14,631
Closed -$144K
FDX icon
192
FedEx
FDX
$74.7B
– –
-754
Closed -$212K
OABI icon
193
OmniAb
OABI
$325M
– –
-21,204
Closed -$75.1K
OCUL icon
194
Ocular Therapeutix
OCUL
$1.92B
– –
-11,693
Closed -$99.9K
WGS icon
195
GeneDx Holdings
WGS
$2.08B
– –
-8,303
Closed -$638K
FNA
196
DELISTED
Paragon 28, Inc.
FNA
– –
-16,553
Closed -$171K
INFN
197
DELISTED
Infinera Corporation Common Stock
INFN
– –
-33,883
Closed -$223K
MTTR
198
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
– –
-26,073
Closed -$124K
ZUO
199
DELISTED
Zuora, Inc.
ZUO
– –
-16,152
Closed -$160K
4 5 6 7
8

Similar funds

GMF
Grace & Mercy Foundation New York $410M AUM 12.09% 1-Year Est. Return
TPC
Tiger Pacific Capital New York $410M AUM 0.97% 1-Year Est. Return
KM
KP Management Edina, Minnesota $409M AUM 68.3% 1-Year Est. Return
LPC
Lineage Point Capital Palm Beach, Florida $409M AUM
QCI
Quaker Capital Investments Mount Lebanon, Pennsylvania $409M AUM 61.78% 1-Year Est. Return
LCAM
Long Corridor Asset Management Hong Kong $411M AUM 16.28% 1-Year Est. Return
GCM
G2 Capital Management Columbus, Ohio $411M AUM 14.56% 1-Year Est. Return
HIF
Hill Island Financial Grand Rapids, Michigan $412M AUM 21.46% 1-Year Est. Return

Palumbo Wealth Management's Q1 2025 Portfolio in Review

As of Q1 2025, Palumbo Wealth Management held 199 positions worth $299M, up 12% from $268M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Palumbo Wealth Management deployed $33.1M of net new capital in Q1 2025, opening 24 new positions and adding to 127 existing holdings. Its largest new stake was Eli Lilly: 497 shares worth $411K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $3.8M trimmed.

  • Palumbo Wealth Management's largest Q1 2025 buy was Eli Lilly: 497 shares worth $411K.
  • Palumbo Wealth Management added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q1 2025, an estimated $2.05M increase.
  • Palumbo Wealth Management's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.8M.
  • Palumbo Wealth Management fully exited GeneDx Holdings in Q1 2025, selling an estimated $638K.
  • Palumbo Wealth Management's ten largest holdings make up 40% of its $299M portfolio in Q1 2025.
  • Palumbo Wealth Management opened 24 new positions and closed 12 in Q1 2025.
  • Palumbo Wealth Management's portfolio value rose 12% quarter-over-quarter to $299M.

Based on Palumbo Wealth Management's 13F filing for Q1 2025, filed 22 Apr 2025.